Mastering The Fundamentals Of Oligo Development
Source: Asahi Kasei Bioprocess
By Steve Foy, Product Marketing Manager, Asahi Kasei Bioprocess America
![Asahi Oligo Asahi Oligo](https://vertassets.blob.core.windows.net/image/c5f2e8db/c5f2e8db-1af4-4dd9-bf74-bb74a2355883/375_250-asahi_oligo.jpg)
With over 300 candidates in clinical trials, oligonucleotides are one of the most promising therapeutic modalities and for the foreseeable future – and solid phase synthesis remains the gold standard approach for manufacturing. Benefits include the relative ease of developing a synthesis route, the straightforward path to scale-up and improved in-process controls. For all the complexity that exists in oligonucleotide development – from end to end – a mastery of synthesis fundamentals can go a long way toward a successful run.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Asahi Kasei Bioprocess
This website uses cookies to ensure you get the best experience on our website. Learn more